Commentary · 21 Feb 2026
Conference abstractPublished 15 Aug 2011
Modification of mitochondrial DNA in breast cancer
Vascular and Genomic Research Center, Changhua Christian Hospital, China Department of Neurology, Changhua Christian Hospital, Changhua, China Graduate Institute of Integrated Medicine, China Medical University, China Department of S
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Alterations in mitochondrial DNA have been identified in breast cancer, however, the definite biomarkers of mitochondrial DNA (mtDNA) for cancer detection and prediction of the biological behavior and outcome of breast tumors still need to be confirmed forwardly. The object of this study is to investigate the influences of mitochondrial metabolism and mtDNA polymorphism correlated to histologic subtypes of breast cancer on a biological marker TP53 gene (p53) and clinicopathological parameters such as distal metastasis and disease-free survival (DFS) which measured at 5 years. The copy number, oxidative stress (formation of 8-OHdG in mtDNA), mtDNA 4,977-bp common deletion (mtDNA4977) and somatic mutations in the D-loop region of mtDNA in breast cancer and paired nontumorous breast tissues from TaiwaneseâÂ?Â?patients were examined. We found that tumor group relative to normal group with a higher relative copy number and lower mtDNA oxidation individually displayed high level distal metastasis increase and poorer DFS. High percentage of TP53 mutation only observed in tumor group with a higher relative copy number. For alterations in mtDNA variation in the breast cancer, the mtDNA from tumor tissues with negative mtDNA4977 and high-level of D-loop mutation had high-level increase of TP53 mutation percentage and distal metastasis following the poorer DFS. These results reveled that patients with higher copy number, lower oxidative damage, D-loop mutation of mtDNA and without mtDNA4977, the malignant progression of breast cancer could be raised. The related regulation factor could be related with P53-mediated cell death for cancer cells.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Chin-San Liu”
- BylineArticles whose byline prints “Shou-Dong Chen”
- BylineArticles whose byline prints “Shou-Jen Kuo”
- BylineArticles whose byline prints “Jui-Chih Chang”
- BylineArticles whose byline prints “Ta-Tsung Lin”
